Article metrics

Download PDFPDF

Original research
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: March 2020 to April 2021

AbstractFullPdf
Mar 2020384384147
Apr 202020820875
May 2020949441
Jun 202011611649
Jul 2020707223
Aug 2020838347
Sep 202013613632
Oct 202011511537
Nov 2020858622
Dec 2020848437
Jan 202110910968
Feb 202111611630
Mar 202122522565
Apr 202118518567
Total20102013740